Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,990 total articles

Wise debuts US listing on Nasdaq

Wise debuts US listing on Nasdaq

Wise, a global fintech company specializing in low-cost and instant cross-border money transfers, has commenced trading on Nasdaq while maintaining its London Stock Exchange listing. The firm reported strong financial and operational metrics for the fiscal year ending March 31, 2026, highlighting significant year-over-year growth in transaction vol…

Barrick Board Authorizes $3.0 Billion Share Repurchase

Barrick Board Authorizes $3.0 Billion Share Repurchase

Barrick Mining Corporation's Board has authorized a $3 billion share repurchase program, aiming to capitalize on what it sees as exceptional value in its shares ahead of the planned IPO of North American Barrick. The authorization allows for purchases through various market methods, primarily on the NYSE. This move reflects Barrick's strong free ca…

Barrick Declares Q1 Dividend

Barrick Declares Q1 Dividend

Barrick Mining Corporation announced a fixed base quarterly dividend of $0.175 per share for Q1 2026, payable on June 15, 2026. The dividend aligns with the company’s policy targeting 50% of attributable free cash flow on an annual basis, with payouts adjusted year-end based on performance. Barrick highlighted its extensive global mining operations…

Digital-First Insurer Zen Insurance Launches in the UK via New Applied Systems, One Call and Verisk Collaboration

Digital-First Insurer Zen Insurance Launches in the UK via New Applied Systems, One Call and Verisk Collaboration

Verisk, in collaboration with Applied Systems and One Call, is enabling the launch of Zen Insurance, a digital-first insurance brand in the UK. Zen Insurance offers a fully digital customer experience for car insurance initially, powered by Verisk Ignite’s end-to-end policy management platform and Applied Rating Hub's insurer connectivity. This lau…

Elevra Lithium Announces Agreement to Sell Ewoyaa Project Interest

Elevra Lithium Announces Agreement to Sell Ewoyaa Project Interest

Elevra Lithium Limited has agreed to sell its interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt Co for approximately $71 million in cash, expected to close in Q1 FY27. This transaction will allow Elevra to concentrate on its North American lithium projects, simplify its corporate structure, and eliminate further funding comm…

RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

RadNet, Inc. announced record financial results for the first quarter of 2026, with total company revenue increasing 22.1% year-over-year to $575.6 million and Adjusted EBITDA rising 36.3% to $63.3 million. The company also raised its full-year 2026 financial guidance for its Imaging Center segment on revenue, Adjusted EBITDA, and Free Cash Flow, w…

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

MoonLake Immunotherapeutics announced a positive outcome from its final pre-BLA meeting with the U.S. FDA regarding sonelokimab for hidradenitis suppurativa (HS). The FDA accepted the MIRA trial data as substantial evidence of effectiveness and agreed to include adolescent data from the VELA-TEEN trial in the product label. With no remaining regula…

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

argenx announced FDA approval for label expansion of VYVGART and VYVGART Hytrulo to treat all serotypes of adult patients living with generalized myasthenia gravis (gMG), including rare antibody-negative subtypes. The approval is based on positive Phase 3 ADAPT SERON study results showing rapid, significant, and sustained symptom improvement with a…

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing

DSS, Inc. announced that its 2025 annual report (10-K) contains a "going concern" audit qualification by HTL International LLC, indicating significant doubts about the company's ability to continue operations. The disclosure complies with NYSE American regulations and does not alter the financial statements themselves. DSS operates diverse business…

Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)

Shreya Acquisition Group Announces Closing of $110 Million Initial Public Offering (Including Partial Exercise of Over-Allotment Option)

Shreya Acquisition Group, a newly formed special purpose acquisition company (SPAC), has closed its $110 million initial public offering, including partial exercise of its over-allotment option. The units began trading on the NYSE under the ticker SAGUU. The company plans to pursue a business combination with companies primarily in health and welln…

Cornerstone Funds Announce Continuing Monthly Distributions

Cornerstone Funds Announce Continuing Monthly Distributions

Cornerstone Strategic Investment Fund, Inc. (CLM) and Cornerstone Total Return Fund, Inc. (CRF) announced their continuing monthly distributions through September 2026, maintaining their previously adopted monthly distribution policies. These distributions may include net earnings, capital gains, or return-of-capital, with return-of-capital expecte…

NVIDIA Names Suzanne Nora Johnson to Board of Directors

NVIDIA Names Suzanne Nora Johnson to Board of Directors

NVIDIA announced the appointment of Suzanne Nora Johnson, former Vice Chairman of Goldman Sachs and current Pfizer board member, to its board of directors effective July 13, 2026. Johnson will join the Audit Committee, expanding the board to 11 members. Her extensive experience spans finance, technology, and healthcare, providing valuable oversight…